(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.38%) $966.30
(-0.36%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
Live Chart Being Loaded With Signals
Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering...
Stats | |
---|---|
Dagens volum | 2.19M |
Gjennomsnittsvolum | 2.29M |
Markedsverdi | 15.50M |
EPS | $0 ( 2024-04-01 ) |
Neste inntjeningsdato | ( $-0.520 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0300 |
ATR14 | $0.00100 (0.53%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-27 | Lederman Seth | Buy | 1 309 911 | Stock Option |
2024-02-27 | Lederman Seth | Buy | 1 903 680 | Stock Option |
2024-02-27 | Lederman Seth | Buy | 1 309 911 | Stock Option |
2024-02-27 | Lederman Seth | Buy | 235 320 | Stock Option |
2024-02-27 | Saenger Bradley | Buy | 282 000 | Stock Option |
INSIDER POWER |
---|
99.09 |
Last 97 transactions |
Buy: 77 144 979 | Sell: 389 187 |
Volum Korrelasjon
Tonix Pharmaceuticals Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
DYNT | 0.931 |
PXLW | 0.929 |
ATNX | 0.923 |
DSKE | 0.917 |
FTFT | 0.914 |
PRDS | 0.906 |
LIVE | 0.906 |
CIGI | 0.904 |
DGLY | 0.9 |
BYFC | 0.9 |
10 Mest negative korrelasjoner | |
---|---|
JNCE | -0.88 |
UEIC | -0.872 |
UIHC | -0.872 |
QRHC | -0.862 |
HPLTU | -0.86 |
CENX | -0.856 |
EML | -0.854 |
GRPH | -0.852 |
BNIXU | -0.85 |
PWFL | -0.848 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Tonix Pharmaceuticals Korrelasjon - Valuta/Råvare
Tonix Pharmaceuticals Økonomi
Annual | 2023 |
Omsetning: | $7.77M |
Bruttogevinst: | $-1.26M (-16.27 %) |
EPS: | $-6.85 |
FY | 2023 |
Omsetning: | $7.77M |
Bruttogevinst: | $-1.26M (-16.27 %) |
EPS: | $-6.85 |
FY | 2022 |
Omsetning: | $0 |
Bruttogevinst: | $-112.09M (0.00 %) |
EPS: | $-20.11 |
FY | 2021 |
Omsetning: | $0.00 |
Bruttogevinst: | $0.00 (0.00 %) |
EPS: | $-0.976 |
Financial Reports:
No articles found.
Tonix Pharmaceuticals
Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candidates. The company's immunology portfolio includes biologics to address organ transplant rejection, autoimmunity, and cancer, including TNX-1500, a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft and xenograft rejection and for the treatment of autoimmune diseases. Its rare disease portfolio comprises TNX-2900 for the treatment of Prader-Willi syndrome. The company's infectious disease pipeline includes TNX-801, a vaccine to prevent smallpox and monkeypox; TNX-1840 and TNX-1850 that are live virus vaccines based on its recombinant pox vaccine (RPV) platform for COVID-19; TNX-3500, a small molecule antiviral drug to treat acute COVID-19; and TNX-102 SL, a small molecule drug to treat Long COVID, a chronic post-acute COVID-19 condition. Its CNS portfolio includes small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions, including TNX-102 SL, which is in mid-Phase 3 development for the management of fibromyalgia; TNX-1900 that is in development for the prevention of migraine headache; and TNX-1300, a biologic designed to treat cocaine intoxication. The company was founded in 2007 and is headquartered in Chatham, New Jersey.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.